About Fibroblast
Fibroblast is a Healthcare company based in Chicago (United States) founded in 2011, and was acquired by Cerner in October 2020. Patient referral processes are automated by Fibroblasts SaaS platform. Fibroblast has raised $3.23 million across 4 funding rounds from investors including Cerner and Excelerator Titan. The company was acqui-hired. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Care Coordination. Its legal entity is Fibroblast, Inc. Its competitors include eHealth Technologies, RubiconMD and Refer Well; 3 of its 3 listed competitors have raised funding.
Company details
Fibroblast was founded in 2011 in Chicago, United States, and operates as a SaaS platform in the healthcare sector. Patient referrals are automated through the system, with tools provided for providers to manage referrals actively. Operations focus on reducing patient leakage, supporting revenue growth for fee-for-service entities, and mitigating risks for accountable care organizations across the United States.
- Headquarters Chicago, United States
- Stage Acquired
- SectorsHealthcare
- Website fibroblast.com
- Social LinkedIn X Facebook
- Acquired by Cerner (Oct 2020)
- Legal Name Fibroblast, Inc.
Funding Insights of Fibroblast
Fibroblast has successfully raised a total of $3.23M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $500 thousand completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.23M
- Total Rounds 4
- Last Round Seed — $500,000
- Investors Count 1
All 4 funding rounds of Fibroblast with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2020 | $500,000 | Seed | – | – | – |
| Jan 2018 | $2M | Seed | – | – | – |
| Oct 2013 | $727,668 | Seed | – | – | – |
| May 2012 | Seed | – | Excelerate Labs | – |
2 investors in total: 2 institutional.
Investors in Fibroblast
Fibroblast has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Cerner and Excelerator Titan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Startups are accelerated through a 13-week program in Chicago. | exceleratelabs.com | Chicago, United States | ||
Online platform for employee health benefits | 1979 | cerner.com | North Kansas City, United States |
Investor details for Fibroblast
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Fibroblast
4 dated milestones of Fibroblast across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Fibroblast is founded.
- Funding First funding round.
- Funding Latest funding round, Seed, of $500K.
- Exit Acquired by Cerner.
Competitors of Fibroblast
Fibroblast has 3 listed competitors in our database, 3 of them funded. They include eHealth Technologies, RubiconMD and Refer Well.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ehealthtechnologies.com | 2006 | West Henrietta, United States | $55M | 319 | Referral solutions for healthcare providers | |
| rubiconmd.com | 2013 | New York, United States | $37.85M | 62 | Remote consults are enabled between primary care physicians and specialists. | |
| referwell.com | 2015 | New York, United States | $11.75M | Cloud-based platform for healthcare referral management is provided. |
Detailed competitors of Fibroblast
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Fibroblast (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Fibroblast
Complete news archive for Fibroblast
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fibroblast
Fibroblast was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Fibroblast is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Fibroblast is a funded company, having raised a total of $3.23M across 4 funding rounds to date.
Fibroblast was founded in 2011 in Chicago, United States, and operates as a SaaS platform in the healthcare sector. Patient referrals are automated through the system, with tools provided for providers to manage referrals actively. Operations focus on reducing patient leakage, supporting revenue growth for fee-for-service entities, and mitigating risks for accountable care organizations across the United States.
Fibroblast's top competitors include eHealth Technologies, RubiconMD and Refer Well.
Fibroblast has 2 investors. Key investors include Cerner, and Excelerator Titan.
Fibroblast operates through Fibroblast, Inc..
Yes. Fibroblast was acquired by Cerner in October 2020.